The effect of pre-endoscopy maltodextrin beverage on gastric residual volume and patient's well-being: a randomised controlled trial.
Journal
Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288
Informations de publication
Date de publication:
16 11 2023
16 11 2023
Historique:
received:
20
01
2023
accepted:
12
11
2023
medline:
20
11
2023
pubmed:
17
11
2023
entrez:
16
11
2023
Statut:
epublish
Résumé
Prolonged fasting prior to oesophagogastroduodenoscopy (OGDS) could be noxious to patients' well-being. Strict fasting protocol has been used prior to OGDS with the concern of reduced visibility or suboptimal endoscopic assessment. Maltodextrin beverages were also commonly used as the pre-operative carbohydrate loading in enhanced recovery after surgery (ERAS) protocol. Our study aimed to look for the effects of maltodextrin beverage 2 h before OGDS on gastric residual volume and patient's well-being scores. This was a single-blinded, stratified randomised controlled trial, comparing control group (A, received 400 ml of plain water) and carbohydrate loading group (B, received 400 ml of Carborie). The primary objectives were to measure the gastric residual volume (GRV) and patient's well-being scores using visual analogue scale (VAS) scores for hunger, thirst, anxiety, tiredness and general discomfort. Of 80 randomised patients, 78 completed the study (38 received plain water and 40 Carborie). The median (IQR) GRV was not significantly different between group A and B (5.0 ml (20) vs 4.0 ml (19), p = 0.777). Both groups showed significant reduction in VAS scores in all five parameters (p ≤ 0.001). There were no complications attributed to endoscopy in either group. Pre-endoscopy maltodextrin beverage is as safe as clear water with improved patient's well-being in both groups.Clinical Trial Registration: NCT05106933.
Identifiants
pubmed: 37973795
doi: 10.1038/s41598-023-47357-5
pii: 10.1038/s41598-023-47357-5
pmc: PMC10654920
doi:
Substances chimiques
maltodextrin
7CVR7L4A2D
Water
059QF0KO0R
Banques de données
ClinicalTrials.gov
['NCT05106933']
Types de publication
Randomized Controlled Trial
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
20078Informations de copyright
© 2023. The Author(s).
Références
Gastrointest Endosc. 2006 Apr;63(4):566-9
pubmed: 16564853
Can J Anaesth. 1991 May;38(4 Pt 1):425-9
pubmed: 2065409
Ann Surg. 2018 Apr;267(4):623-630
pubmed: 28582271
N Engl J Med. 2001 Mar 1;344(9):665-71
pubmed: 11228282
Br J Anaesth. 1993 Sep;71(3):333-4
pubmed: 8398510
Public Health Rep. 2009 May-Jun;124(3):471-4
pubmed: 19445426
J Clin Anesth. 2006 Mar;18(2):102-7
pubmed: 16563326
Eur J Anaesthesiol. 2009 Feb;26(2):123-7
pubmed: 19142085
Nutrition. 2008 Mar;24(3):212-6
pubmed: 18096368
Anesthesiology. 2011 Mar;114(3):495-511
pubmed: 21307770
J Gastroenterol Hepatol. 2009 Jun;24(6):1095-7
pubmed: 19220672
J Gastroenterol Hepatol. 2022 Jan;37(1):164-168
pubmed: 34397116
Sci Rep. 2022 Oct 17;12(1):17355
pubmed: 36253448
Gastroenterology. 1983 Apr;84(4):747-51
pubmed: 6825986
Endoscopy. 2019 Jun;51(6):574-598
pubmed: 31075800
Can J Anaesth. 1987 Mar;34(2):117-21
pubmed: 3829296
Obes Rev. 2002 Feb;3(1):9-15
pubmed: 12119661
Anesth Analg. 2013 Aug;117(2):305-13
pubmed: 23757474
Surg Obes Relat Dis. 2013 Sep-Oct;9(5):714-7
pubmed: 22571886
Curr Opin Anaesthesiol. 2007 Dec;20(6):540-4
pubmed: 17989547
Anesthesiology. 2006 Nov;105(5):885-91
pubmed: 17065880
Anesth Pain Med. 2021 Feb 03;11(1):e109732
pubmed: 34221937
Anesth Analg. 2014 Jun;118(6):1268-73
pubmed: 24384864
BMC Gastroenterol. 2013 Nov 09;13:158
pubmed: 24209639
Anesth Analg. 2001 Nov;93(5):1344-50
pubmed: 11682427
Br J Anaesth. 2004 Oct;93(4):497-500
pubmed: 15361474
Indian J Anaesth. 2010 Sep;54(5):445-7
pubmed: 21189883
Can J Anaesth. 1988 Jan;35(1):12-5
pubmed: 3349549
Int J Obes Relat Metab Disord. 2000 Jul;24(7):899-905
pubmed: 10918538
Br J Surg. 2003 Apr;90(4):400-6
pubmed: 12673740
Can Urol Assoc J. 2011 Oct;5(5):342-8
pubmed: 22031616